Skip to main content
Gut logoLink to Gut
. 1987 Feb;28(2):226–229. doi: 10.1136/gut.28.2.226

Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.

C Manniche, A Malchow-Møller, J R Andersen, C Pedersen, T M Hansen, P Jess, L Helleberg, S N Rasmussen, U Tage-Jensen, S E Nielsen
PMCID: PMC1432982  PMID: 3549473

Abstract

Sixty-seven patients with rheumatic disease, treated with non-steroidal anti-inflammatory drugs (NSAIDs), entered a controlled trial with a diagnosis of duodenal (n = 51), gastric (n = 14), or gastric and duodenal (n = 2) ulcers. The main objectives of the study were a comparison of ranitidine and sucralfate in ulcer treatment, and to observe the influence of continued NSAID administration during peptic ulcer therapy. Ulcers healed within nine weeks in 52 patients. The mean healing time was similar in 27 patients given ranitidine 150 mg bd (4.9 weeks) and 25 patients given sucralfate 1 g qid (4.6 weeks). In patients with unhealed ulcers after nine weeks of treatment, healing was obtained in seven after further therapy for 3-9 weeks. Of the 30 patients who continued NSAIDs during treatment with either ranitidine or sucralfate, 23 ulcers healed (mean healing time: 5.0 weeks). Of 32 patients in whom NSAIDs were stopped, ulcer healing was documented in 29 (mean healing time: 4.6 weeks). The difference in healing rates was not statistically significant (p greater than 0.10). The outcome of ulcer treatment did not differ in patients with rheumatoid arthritis and patients suffering from osteoarthritis. During a 12 month follow up 14 symptomatic ulcer recurrences were recorded.

Full text

PDF
226

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs. 1984 Mar;27(3):194–209. doi: 10.2165/00003495-198427030-00002. [DOI] [PubMed] [Google Scholar]
  2. Caruso I., Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. Br Med J. 1980 Jan 12;280(6207):75–78. doi: 10.1136/bmj.280.6207.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Collier D. S., Pain J. A. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut. 1985 Apr;26(4):359–363. doi: 10.1136/gut.26.4.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Croker J. R., Cotton P. B., Boyle A. C., Kinsella P. Cimetidine for peptic ulcer in patients with arthritis. Ann Rheum Dis. 1980 Jun;39(3):275–278. doi: 10.1136/ard.39.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kurata J. H., Elashoff J. D., Grossman M. I. Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleeding. Gastroenterology. 1982 Feb;82(2):373–376. [PubMed] [Google Scholar]
  6. Lanza F. L. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med. 1984 Jul 13;77(1A):19–24. doi: 10.1016/s0002-9343(84)80014-5. [DOI] [PubMed] [Google Scholar]
  7. O'Laughlin J. C., Silvoso G. K., Ivey K. J. Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin. A double-blind study with cimetidine and follow-up. Dig Dis Sci. 1982 Nov;27(11):976–980. doi: 10.1007/BF01391742. [DOI] [PubMed] [Google Scholar]
  8. Peterson W. L., Elashoff J. Placebos in clinical trials of duodenal ulcer: the end of an era? Gastroenterology. 1980 Sep;79(3):585–588. [PubMed] [Google Scholar]
  9. Rees W. D., Turnberg L. A. Reappraisal of the effects of aspirin on the stomach. Lancet. 1980 Aug 23;2(8191):410–413. doi: 10.1016/s0140-6736(80)90452-3. [DOI] [PubMed] [Google Scholar]
  10. Silvoso G. R., Ivey K. J., Butt J. H., Lockard O. O., Holt S. D., Sisk C., Baskin W. N., Mackercher P. A., Hewett J. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med. 1979 Oct;91(4):517–520. doi: 10.7326/0003-4819-91-4-517. [DOI] [PubMed] [Google Scholar]
  11. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]
  12. Sun D. C., Roth S. H., Mitchell C. S., Englund D. W. Upper gastrointestinal disease in rheumatoid arthritis. Am J Dig Dis. 1974 May;19(5):405–410. doi: 10.1007/BF01255603. [DOI] [PubMed] [Google Scholar]
  13. Thomas J. M., Misiewicz G. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer. Clin Gastroenterol. 1984 May;13(2):501–541. [PubMed] [Google Scholar]
  14. Zeldis J. B., Friedman L. S., Isselbacher K. J. Ranitidine: a new H2-receptor antagonist. N Engl J Med. 1983 Dec 1;309(22):1368–1373. doi: 10.1056/NEJM198312013092206. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES